文献速递慢阻肺

量化COPD作为心脏病风险因素:一项初级预防队列研究

Quantifying COPD as a risk factor for cardiac disease in a primary prevention cohort.
PubMed 文献 · Eur Respir J · 2023-08-31

调整心血管危险因素和合并症后,COPD患者MACE发生率比无COPD者高25%(HR 1.25,95%CI 1.23-1.27),提示需对COPD人群加强心血管初级预防。

要点

  • 无心血管病史的COPD患者MACE风险较无COPD者高25%(HR 1.25,95%CI 1.23-1.27)。
  • 该风险增幅与糖尿病患者相当,支持将COPD视为心血管初级预防的高危因素。
  • COPD患者需更积极的心血管危险因素筛查与初级预防管理。

核心结论

  • 在无心血管病史的真实世界大样本人群中,医生诊断的COPD患者发生主要不良心血管事件的风险比无COPD者高25%(HR 1.25,95%CI 1.23-1.27),该风险增幅与糖尿病患者相当。

研究设计与样本

  • 回顾性人群队列研究,使用加拿大安大略省健康行政、用药、实验室和电子病历等数据,纳入2008至2016年随访的无心血管病史且年龄≥40岁人群,比较有无医生诊断COPD者的心脏危险因素和合并症,并用序贯病因特异性风险模型调整后评估MACE风险。

主要发现

  • 调整心血管危险因素、合并症及其他变量后,COPD患者MACE发生率比无COPD者高25%(HR 1.25,95%CI 1.23-1.27)。

临床怎么用

  • 对无心血管病史的COPD患者,应像对待糖尿病患者一样重视心血管初级预防,更积极地评估和管理心血管危险因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite COPD being a risk factor for cardiovascular disease (CVD) and knowing that risk stratification for CVD primary prevention is important, little is known about the real-world risk of CVD among people with COPD with no history of CVD. This knowledge would inform CVD management for people with COPD. The current study aimed to examine the risk of major adverse cardiovascular events (MACE) (including acute myocardial infarction, stroke or cardiovascular death) in a large, complete real-world population with COPD without previous CVD. METHODS: We conducted a retrospective population cohort study using health administrative, medication, laboratory, electronic medical record and other data from Ontario, Canada. People without a history of CVD with and without physician-diagnosed COPD were followed between 2008 and 2016, and cardiac risk factors and comorbidities compared. Sequential cause-specific hazard models adjusting for these factors determined the risk of MACE in people with COPD. RESULTS: Among ∼5.8 million individuals in Ontario aged ≥40 years without CVD, 152 125 had COPD. After adjustment for cardiovascular risk factors, comorbidities and other variables, the rate of MACE was 25% higher in persons with COPD compared with those without COPD (hazard ratio 1.25, 95% CI 1.23-1.27). CONCLUSIONS: In a large real-world population without CVD, people with physician-diagnosed COPD were 25% more likely to have a major CVD event, after adjustment for CVD risk and other factors. This rate is comparable to the rate in people with diabetes and calls for more aggressive CVD primary prevention in the COPD population.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Maclagan LC, Croxford R, Chu A, et al. Quantifying COPD as a risk factor for cardiac disease in a primary prevention cohort. Eur Respir J. 2023. PMID: 37385658. doi:10.1183/13993003.02364-2022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。